Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CCNC | P24863 | 1/20 | 0.32 |
| ▸ | CDK8 | P49336 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15851693 | 0.94 | TDP1 (0.33) | TDP1 | |
| SCHEMBL15851694 | 0.94 | MAOB (0.36) | TDP1CCNCCDK8MAOBMEN1 | |
| SCHEMBL19308034 | 0.94 | MEN1 (0.31) | TDP1MEN1THRBRECQLBLM | |
| SCHEMBL19308037 | 0.93 | MAPT (0.32) | TDP1MEN1THRBRECQLBLM | |
| SCHEMBL15851704 | 0.93 | PLA2G2A (0.31) | TDP1CCNCCDK8MEN1THRB | |
| SCHEMBL19308024 | 0.93 | TDP1 (0.37) | TDP1MAOB | |
| SCHEMBL15851703 | 0.93 | MEN1 (0.31) | TDP1MEN1THRBRECQLBLM | |
| SCHEMBL19308057 | 0.92 | CCNC (0.34) | TDP1CCNCCDK8MAOB | |
| SCHEMBL15851696 | 0.91 | TDP1 (0.33) | TDP1CCNCCDK8MEN1THRB | |
| SCHEMBL15852944 | 0.91 | MAOB (0.34) | TDP1MAOBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10270040-B2 | Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-04-23 | — | — | US | disclosed |
| US-20170324043-A1 | OXYGEN-CONTAINING FUSED RING AMINE COMPOUND, SULFUR-CONTAINING FUSED RING AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170324043-A1 | OXYGEN-CONTAINING FUSED RING AMINE COMPOUND, SULFUR-CONTAINING FUSED RING AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-11-09 | — | — | US | disclosed |
| US-9755156-B2 | Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2017-09-05 | — | — | US | disclosed |
| US-9755156-B2 | Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2017-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10270040-B2 | Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device | AOC2, SQOR, AOC1 | TDP1 3483/4885CCNC 1852/4885CDK8 2289/4885 |
| US-20170324043-A1 | OXYGEN-CONTAINING FUSED RING AMINE COMPOUND, SULFUR-CONTAINING FUSED RING AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | AOC2, SQOR, AOC1 | TDP1 3483/4885CCNC 1852/4885CDK8 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.